Articles

Most children are infected with the human metapneumovirus (HMPV) by the age of five. The virus is capable of causing potentially fatal upper and lower respiratory tract illnesses. Elderly people and young children who are initially exposed to viruses are high-risk groups. There is currently no approved vaccination or standard therapy for HMPV. Raising awareness of HMPV's effects on public health is necessary to spur research, finish developing a vaccine, and avert serious virus-related illnesses and deaths around the world. This article aimed to overview the human metapneumovirus, the causative agent, how spread, symptoms, and treatment.